Literature DB >> 26847997

CT and clinical findings of peripheral primitive neuroectodermal tumour in children.

Huijuan Xiao1, Fengchang Bao2, Hongna Tan1, Bo Wang1, Wei Liu2, Jianbo Gao1, Xianzheng Gao3.   

Abstract

OBJECTIVE: To describe the clinical, CT and pathological findings of paediatric peripheral primitive neuroectodermal tumours (pPNETs) to enhance the recognition of these rare tumours.
METHODS: The clinical, CT and pathological findings of 18 paediatric patients with pPNETs confirmed by biopsy or surgical pathology were retrospectively reviewed.
RESULTS: The age of these 18 paediatric patients with pPNETs ranged from 4 months to 15 years, with a mean age of 7.7 years. The lesions of these 18 paediatric patients with pPNETs were located in the head and neck (n = 4), chest (n = 2), abdomen and pelvic cavity (n = 6), spine (n = 3), ilium (n = 2) and femur (n = 1). Immunohistochemical examination revealed Homer-Wright rosettes in seven lesions, and 94.4% of lesions showed consistent positive staining for CD99. On plain CT images, the majority of pPNETs showed lesions that were ill-defined (72.2%), irregularly shaped (83.3%), heterogeneous (66.7%) or hypodense masses (94.4%), and together with osteolytic bone destruction when the lesion originated in the bone. Calcifications were found in three lesions. After contrast administration, all soft-tissue masses were persistently enhanced heterogeneously with various cystic or necrotic regions, and 71.4% of them had linear enhancement. 94.4% of soft-tissue masses showed a moderate degree of enhancement. Seven cases had lymph node metastasis at diagnosis.
CONCLUSION: Paediatric pPNET can involve any part of the body, and a large, ill-defined, aggressive soft-tissue mass and moderate heterogeneous enhancement with varying cystic regions and linear enhancement, with or without osteolytic bone destruction, on CT images could suggest the diagnosis. ADVANCES IN KNOWLEDGE: Primitive neuroectodermal tumours constitute a rare type of malignant neuroectodermal tumours that have chromosomal translocations identical to Ewing's sarcoma, and reports about radiological characteristics of this disease in children are insufficient. This study has described the clinical features and CT and pathological findings in 18 paediatric patients diagnosed with pPNETs in different locations, as a way to enhance the recognition of these tumours and help to differentiate from other types of paediatric malignant bone and soft-tissue tumours.

Entities:  

Mesh:

Year:  2016        PMID: 26847997      PMCID: PMC4846188          DOI: 10.1259/bjr.20140450

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  22 in total

Review 1.  Imaging features of peripheral primitive neuroectodermal tumours.

Authors:  S Hari; T P Jain; S Thulkar; S Bakhshi
Journal:  Br J Radiol       Date:  2008-09-01       Impact factor: 3.039

Review 2.  Ewing sarcoma/peripheral primitive neuroectodermal tumor and related tumors.

Authors:  Maria Tsokos; Rita D Alaggio; Louis P Dehner; Paul S Dickman
Journal:  Pediatr Dev Pathol       Date:  2012

3.  Computed tomography and magnetic resonance imaging findings of peripheral primitive neuroectodermal tumors of the head and neck.

Authors:  Wei-dong Zhang; Yan-feng Chen; Chuan-xing Li; Liang Zhang; Zhi-bin Xu; Fu-jun Zhang
Journal:  Eur J Radiol       Date:  2011-02-26       Impact factor: 3.528

Review 4.  Imaging findings in mandibular primitive neuroectodermal tumour: a report of a rare case and review of the literature.

Authors:  C H Yeh; K M Yeow; S Y Chu; K T Pan; C F Hung; S Hsueh; I H Su
Journal:  Dentomaxillofac Radiol       Date:  2011-10       Impact factor: 2.419

5.  Thoracoabdominal peripheral primitive neuroectodermal tumors in childhood: radiological features.

Authors:  H Schulman; N Newman-Heinman; E Kurtzbart; E Maor; H Zirkin; L Laufer
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

6.  Primitive neuroectodermal tumor arising in the abdominopelvic region: CT features and pathology characteristics.

Authors:  Xinchun Li; Weidong Zhang; Ting Song; Chongpeng Sun; Yuechun Shen
Journal:  Abdom Imaging       Date:  2011-10

Review 7.  The WHO classification of tumors of the nervous system.

Authors:  Paul Kleihues; David N Louis; Bernd W Scheithauer; Lucy B Rorke; Guido Reifenberger; Peter C Burger; Webster K Cavenee
Journal:  J Neuropathol Exp Neurol       Date:  2002-03       Impact factor: 3.685

Review 8.  Peripheral and central primitive neuroectodermal tumors. A nosologic concept seeking a consensus.

Authors:  L P Dehner
Journal:  Arch Pathol Lab Med       Date:  1986-11       Impact factor: 5.534

9.  Primitive neuroectodermal tumour (PNET) of the kidney: a rare renal tumour in adolescents with seemingly characteristic radiological features.

Authors:  Winnie C Chu; Boris Reznikov; Edward Y Lee; Ronald M Grant; Frankie W T Cheng; Paul Babyn
Journal:  Pediatr Radiol       Date:  2008-08-19

10.  Treatment outcomes in 23 thoracic primitive neuroectodermal tumours: a retrospective study.

Authors:  Srikrishna Sirivella; Isaac Gielchinsky
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-05-02
View more
  4 in total

1.  Triple-phase 99mTc-3P-RGD2 imaging of peripheral primitive neuroectodermal tumor in the hip muscle group with bone metastasis.

Authors:  Jingjing Fu; Jinhua Song; Youcai Zhao; Feng Wang; Guoqiang Shao
Journal:  Mol Clin Oncol       Date:  2016-12-28

2.  Primitive Neuroectodermal Tumour of Subcutaneous Tissue Presenting as a Shoulder Lump: A Case Report.

Authors:  Shankar Poudel; Upama Sangroula; Ashik Rajak
Journal:  JNMA J Nepal Med Assoc       Date:  2022-03-11       Impact factor: 0.556

3.  Primitive Neuroectodermal Tumour Invading the Inferior Vena Cava.

Authors:  Ali Mir; Marzieh Lashkari; Fatemeh Jafari; Behnam Molavi
Journal:  Eur J Case Rep Intern Med       Date:  2020-04-07

4.  Primary primitive neuroectodermal tumor in the pericardium-a focus on imaging findings: A case report.

Authors:  Shu-Ming Xu; Juan Bai; Jin-Hua Cai
Journal:  World J Clin Cases       Date:  2021-06-16       Impact factor: 1.337

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.